Skip to Content

ESMO | European Society for Medical Oncology

ESMO 2025

Improved PFS and OS in HER2-Positive and Triple-Negative Breast Cancer

  • / Hanne Melgaard Nielsen / Jan Andreasen

Articles from ESMO 2025

Medtalks from ESMO 2025

Back to top